Characterization and Prediction of Early Onset Diabetic Peripheral Neuropathy

Recruiting now

Conditions studied: Neuropathy, Diabetic, Small Nerve Fiber Neuropathy, Type 1 Diabetes

In brief

Predicting early onset neuropathy in people with type 1 diabetes

Key facts

Study ID

NCT05546138

Run by

Aalborg University Hospital

People needed

200

Starts

2023-10-01

Expected to finish

2029-12-31

Last updated by the study team

2024-06-28

Who can join

Age: 18 and older, up to 60. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Men and women aged 18-80 years
• Diagnosed with diabetes (of any type)
• No clinically established diabetic peripheral neuropathy at inclusion

You may not qualify if…

• Alcohol or drug abuse within the last year (prior to inclusion)
• Chemotherapy (prior or within study period) or experimental medicine
• Severe vitamin deficiencies
• Inability to understand or comply with the examinations
• Planned or likely discontinuation of care at Aalborg University Hospital
• Known hematologic disorders resulting in a markedly reduced ability to stop small bleedings
• Severe limb ischemia
• Active diabetic foot ulcers
• Previous amputations
• Severe skin diseases or diseases known to cause neural damage
• Pregnancy at inclusion

Where it is running

• Aalborg University Hospital — Aalborg, Denmark (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.